MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2

Jianyi Pang, Limei Dai, Chen Zhang, Qinglei Zhang

Open source

DOI
10.1155/2021/6974225
Published
2021-06-29
Container
Journal of Healthcare Engineering
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/6974225,
  title = {MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2},
  author = {Jianyi Pang and Limei Dai and Chen Zhang and Qinglei Zhang},
  year = {2021},
  journal = {Journal of Healthcare Engineering},
  doi = {10.1155/2021/6974225},
  url = {https://doi.org/10.1155/2021/6974225}
}

RIS

TY  - JOUR
TI  - MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
AU  - Jianyi Pang
AU  - Limei Dai
AU  - Chen Zhang
AU  - Qinglei Zhang
PY  - 2021
JO  - Journal of Healthcare Engineering
DO  - 10.1155/2021/6974225
UR  - https://doi.org/10.1155/2021/6974225
ER  - 

APA

Pang, J., Dai, L., Zhang, C., & Zhang, Q. (2021). MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2. Journal of Healthcare Engineering. https://doi.org/10.1155/2021/6974225

Source records